focus -WSS

focus

author：explore 2025-10-01 02:13:57 - browse：91

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Security flaws in third

focus

WSS

What affirmative action's end means to a medical student

How to keep neuroscience’s past racism from being its future

Hospitals owned by private equity see complications spike 25%

Crowdfunding for unproven stem cell procedures spreads misinformation

Editas, Vertex strike deal on CRISPR

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Wikipedia

focus

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

A letter from the executive editor: The 2023 STATUS List

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medicare Advantage beneficiaries sue Humana over algorithm use

Dobbs anniversary: the lost opportunity of abortion as health care

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

The high cost of giving birth even with insurance

David Ricks of Eli Lilly: best biopharma CEO of 2023

Bright Health sells Medicare Advantage business to Molina

Why health care costs have stayed mostly flat since 2010

knowledge

Medicare drug price negotiation hasn't dried up venture capital

Use doctors trained outside the U.S. to ease the physician shortage

Violet CEO on training clinicians to promote more inclusive care

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Grail spinoff by Illumina should end disastrous merger attempt

HCA sued by state AG for quality issues at Mission Health

focus

focus

focus

Wikipedia